Average Co-Inventor Count = 7.73
ph-index = 4
The patent ph-index is calculated by counting the number of publications for which an author has been cited by other authors at least that same number of times.
Company Filing History:
1. Eli Lilly and Company (4 from 4,442 patents)
2. Glaxosmithkline LLC (3 from 356 patents)
3. Icagen, Inc. (1 from 101 patents)
7 patents:
1. 7981903 - 2-[2-{phenylamino}-1H-pyrrolo[2,3-D]pyrimidin-4-yl)amino] benzamide derivatives as IGF-1R inhibitors for the treatment of cancer
2. 7812022 - 2-pyrimidinyl pyrazolopyridine ErbB kinase inhibitors
3. 7807673 - 2-pyrimidinyl pyrazolopyridine ErbB kinase inhibitors
4. 6429317 - Indane derivatives for antipsychotic compositions
5. 6395735 - Pharmaceutical compounds
6. 6221876 - Methods for inhibiting MRP1
7. 6083986 - Potassium channel inhibitors